EXAS+96.76%10.0%
GH+219.91%10.0%
GRAL+74.67%10.0%
ICAD0.00%10.0%
MASS+12.60%10.0%
NVCR-6.34%10.0%
PACB+7.33%10.0%
PSNL+111.71%10.0%
RDNT+14.68%10.0%
TOI+103.83%10.0%
As of Jul 10, 2026, 7:14 AM ET
MedTech Long '25: Cancer Diagnostics, Platforms & Care Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Guardant Health, Inc.GH | 10.0% | 1.47% | 5.06% | 6.73% | -3.92% | 60.64% | 74.74% | 277.28% | 219.91% | $21.76B |
Exact Sciences CorporationEXAS | 10.0% | 0.00% | 0.00% | 0.00% | 0.00% | 3.30% | 1.48% | 135.44% | 96.76% | $20.03B |
RadNet, Inc.RDNT | 10.0% | -4.15% | 0.53% | 11.23% | 0.49% | -7.58% | -5.54% | 25.58% | 14.68% | $5.19B |
GRAIL, Inc.GRAL | 10.0% | -0.05% | 8.06% | 10.82% | 11.28% | -11.45% | 42.38% | 189.94% | 74.67% | $3.25B |
Novocure LtdNVCR | 10.0% | -0.09% | -0.46% | 11.69% | 9.57% | 33.72% | 26.48% | -3.62% | -6.34% | $2.00B |
Personalis, Inc.PSNL | 10.0% | 0.07% | 3.83% | 6.55% | 6.24% | 84.05% | 61.70% | 311.52% | 111.71% | $1.30B |
The Oncology Institute, Inc.TOI | 10.0% | 1.88% | 3.54% | 4.46% | 6.17% | 64.33% | 102.42% | 295.27% | 103.83% | $584.9M |
Pacific Biosciences of California, Inc.PACB | 10.0% | 1.55% | 7.33% | -6.94% | -7.47% | -13.90% | -4.17% | 26.77% | 7.33% | $500.1M |
908 Devices Inc.MASS | 10.0% | 0.00% | 3.17% | -7.72% | -8.45% | 54.86% | 17.83% | 108.46% | 12.60% | $307.4M |
iCAD, Inc.ICAD | 10.0% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $56.6M |
| Theme return | — | 0.07% | 3.11% | 3.68% | 1.47% | 33.81% | 33.34% | 157.88% | 79.34% | — |
| Average | 10.0% | 0.07% | 3.11% | 3.68% | 1.39% | 26.80% | 31.73% | 136.66% | 63.52% | $5.50B |
| Median | 10.0% | 0.00% | 3.36% | 5.51% | 0.25% | 18.51% | 22.16% | 121.95% | 44.68% | $1.65B |
| Std Dev | 0.0% | 1.59% | 2.93% | 6.78% | 6.48% | 34.98% | 35.61% | 119.13% | 68.33% | $7.85B |
| Min | 10.0% | -4.15% | -0.46% | -7.72% | -8.45% | -13.90% | -5.54% | -3.62% | -6.34% | $56.6M |
| Max | 10.0% | 1.88% | 8.06% | 11.69% | 11.28% | 84.05% | 102.42% | 311.52% | 219.91% | $21.76B |
| % Positive Tickers | 40.00% | 70.00% | 60.00% | 50.00% | 60.00% | 70.00% | 80.00% | 80.00% |
About this theme
MedTech Long '25: Cancer Diagnostics, Platforms & Care tracks 10 publicly listed stocks in this theme: EXAS, GH, GRAL, ICAD, MASS, NVCR, PACB, PSNL, RDNT, TOI. See the constituent table for details.